Patents by Inventor William T. Jackson

William T. Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8726351
    Abstract: Systems and/or methods for controlling access to a plurality of records and/or documentary materials to be persisted in an electronic archives system are provided. The plurality of records and/or documentary material and all preserved information may be stored and accessed on the basis of user and/or object attributes. The user attributes include group affiliation, ownership, and state (e.g., workflow step and time of day). The object attributes include group affiliation, business role, clearance or access level, and network address from which access is requested. Access to the plurality of records and/or documentary material can be obtained both from within a single security domain as well as across more than one security domain.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: May 13, 2014
    Assignees: Lockheed Martin Corporation, Electric Data Systems Corporation, Business Performance Systems, Fenestra Technologies Corporation
    Inventors: Richard L. Metzer, James E. Grant, William T. Jackson, David P. Isaac, Matthew J. McKennirey, Kenneth L. Bedford
  • Patent number: 6131983
    Abstract: The present invention is a cloth tarpaulin or liner especially for pick up truck beds. The tarpaulin is formed to the specifications of a truck bed and easily hooks to the back of a truck. The device aids the removal and unloading of bulk materials and hard to remove items such as slag, sand, etc. The tarpaulin ultimately allows a minimal amount of clean up after unloading the truck. The tarpaulin covers the bed of the truck and has pull lines on the front of it so it can be pulled off the bed easily. This can be achieved with another automobile or it can be tied down and moved forward. Any type of material able to withstand heavy use can be suited for this invention.
    Type: Grant
    Filed: August 18, 1999
    Date of Patent: October 17, 2000
    Inventor: William T. Jackson
  • Patent number: 5998454
    Abstract: This invention provides methods for the treatment or inhibiting of iritis which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: December 7, 1999
    Assignee: Eli Lilly and Company
    Inventors: Jerome H. Fleisch, William T. Jackson, Jason S. Sawyer
  • Patent number: 5914340
    Abstract: This invention provides methods for the treatment or inhibiting of dermatitis which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: June 22, 1999
    Assignee: Eli Lilly and Company
    Inventors: Jerome H. Fleisch, William T. Jackson, Jason S. Sawyer
  • Patent number: 5910505
    Abstract: This invention provides methods for the treatment or inhibitor of oral squamous cell carcinoma which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: June 8, 1999
    Assignee: Eli Lilly and Company
    Inventors: Jerome H. Fleisch, William T. Jackson, Jason S. Sawyer
  • Patent number: 5817684
    Abstract: This invention provides methods for the treatment or prevention of cerebral focal ischemia which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: October 6, 1998
    Assignee: Eli Lilly and Company
    Inventors: Jerome H. Fleisch, William T. Jackson, Jason S. Sawyer
  • Patent number: 5532382
    Abstract: Provided are compounds of the formula II ##STR1## wherein R.sub.6 and R.sub.7 are independently hydrogen or C.sub.1 -C.sub.6 alkyl;R.sub.5 is naphthyl, substituted nephthyl, or phenyl substituted one to three times with C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkyl, phenyl, or hydroxy; with the proviso that if the phenyl is substituted once with hydroxy, it must be further be substituted once or twice with C.sub.1 -C.sub.6 alkoxy, C.sub.l -C.sub.6 alkyl, phenyl or hydroxy, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: July 2, 1996
    Assignee: Eli Lilly and Company
    Inventors: Donald G. Carlson, George J. Cullinan, Kennan J. Fahey, William T. Jackson, Neal W. Roehm, Stephen M. Spaethe
  • Patent number: 5514704
    Abstract: A method of inhibiting leukotrienes comprising administering to a mammal in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen or C.sub.1 -C.sub.6 alkyl;R.sub.3 is hydrogen, or a group of the formula ##STR2## wherein R.sub.4 is phenyl, substituted phenyl, naphthyl or substituted naphthyl, with the proviso that when R.sub.1 and R.sub.2 are both C.sub.1 -C.sub.6 alkyl, R.sub.3 is not hydrogen; and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: May 7, 1996
    Assignee: Eli Lilly and Company
    Inventors: Donald G. Carlson, George J. Cullinan, Kennan J. Fahey, William T. Jackson, Neal W. Roehm, Stephen M. Spaethe
  • Patent number: 5514703
    Abstract: A method of inhibiting 5-lipoxygenase comprising administering to a mammal in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen or C.sub.1 -C.sub.6 alkyl;R.sub.3 is hydrogen, or a group of the formula ##STR2## wherein R.sub.4 phenyl, substituted phenyl, naphthyl or substituted naphthyl, with the proviso that when R.sub.1 and R.sub.2 are both C.sub.1 -C.sub.6 alkyl, R.sub.3 is not hydrogen; and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: May 7, 1996
    Assignee: Eli Lilly and Company
    Inventors: Donald G. Carlson, George J. Cullinan, Kennan J. Fahey, William T. Jackson, Neal W. Roehm, Stephen M. Spaethe
  • Patent number: PP10115
    Abstract: A new and distinct variety of `Jonathan` apple tree originating as a limb mutation of the Malus sylvestris variety of `Jonnee`, Robison cultivar (U.S. Plant Pat. No. 2,934)This new sport is unique from its parent because the fruit starts coloring 30 days earlier and the color develops as a solid, rich red blush with no striping. The color finishes virtually 100% solid as a deep ruby red. Fan 1, Red Group 46A to 45C.The commercial harvest maturity is 7 days earlier than its parent. At harvest, the internal flesh color is much creamier yellow color that the parent. Fan 1, Yellow Group 11 D. The fruit skin is significantly smoother and much less prone to stem end russet and scarf skin than its parent.
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: November 11, 1997
    Inventors: William T. Jackson, Shirley W. Jackson